This content is from: Home

From antibodies to X-rays: an overview of patent eligibility in Canada

The trend for deciding patentability based on subject-matter eligibility is growing. David Schwartz and Sanro Zlobec of Smart & Biggar look at the situation in Canada, where the relevant jurisprudence remains scant

To access our in-house intelligence please request a trial here.

Read this article – and more – for a 30 day period.


Are you already an Managing IP subscriber? Login here


Instant access to all of our content. Membership Options | 30 Day Trial